INTRODUCTION {#sec1-1}
============

Adverse pregnancy outcomes (preterm birth \[PTB\], low birth weight \[LBW\], and preterm LBW \[PTLBW\]) remain an important public health problem as it is still encountered across several communities globally and pose a considerable challenge to health professionals. PTB is defined as live birth \<37 weeks of gestation, and LBW was defined by the World Health Organization in 1976 as a birth weight lower than 2500 g. The proven risk factors for adverse pregnancy outcomes were young and advanced maternal age, multiple gestations, previous PTB, short cervix, low educational status, stress, diabetes, short interpregnancy interval, and fetal genotype.\[[@ref1]\] Poor maternal health also plays an important role in the occurrence of adverse pregnancy outcomes. Periodontitis is a chronic destructive inflammatory disease affecting the supporting structures of the tooth which is initiated by the dental plaque with the predominance of Gram-negative anaerobic microorganisms and also mediated by the host inflammatory response. The transit of periodontal pathogens and inflammatory mediators from the periodontal pocket to the fetal placental unit triggering inflammatory cascade could be a plausible link between the periodontal disease and the occurrence of the adverse pregnancy outcomes. This association is inconsistent as shown in previous epidemiological studies.\[[@ref2][@ref3][@ref4][@ref5]\]

Various epidemiological studies have shown that periodontal therapy during pregnancy reduces the occurrence of adverse pregnancy outcomes.\[[@ref2][@ref6][@ref7][@ref8]\] Preventive strategies implemented during the antenatal period have shown to improve pregnancy outcomes and oral health. Recommendations from health experts suggest women to undergo dental examination and therapeutic intervention during the preconception stage and during pregnancy.\[[@ref9]\] However, the consensus statement of the (European Federation of Periodontology-American Academy of Periodontology) EFP-AAP workshop concluded periodontal therapy during pregnancy with or without systemic antibiotics, does not reduce the overall rates of adverse pregnancy outcomes.\[[@ref10]\]

Several systematic reviews and meta-analysis conducted to assess the effect of periodontal therapy on the occurrence of adverse pregnancy outcomes among mothers with poor oral health have yielded inconclusive results.\[[@ref11][@ref12]\] The discordant results can be attributed to the low quality of the trials and the inclusion of only few published studies. The methodologies used to assess the quality of the studies included were also controversial. Moreover, the previous reviews focused on studies published from 2000 to 2012. Considering the abovementioned limitations and the time gap in the literature, we conducted a systematic review to provide the best possible evidence for the plausible association between periodontal therapy and adverse pregnancy outcomes among pregnant mothers with poor oral health. We included the studies published until 2018 for this present review.

MATERIALS AND METHODS {#sec1-2}
=====================

Types of studies {#sec2-1}
----------------

Randomized controlled trials (RCTs) offer the best possible evidence for assessing the effectiveness of therapeutic procedures. Hence, we included all the RCTs that assessed the influence of periodontal therapy at least on any one of these adverse pregnancy outcomes (PTB, LBW, and PTLBW). Reviews, case reports, editorials, *in vitro* studies, commentaries, animal studies, qualitative studies, case--control studies, cohort studies, and studies reported in other languages except English were excluded from this review. Only full-text articles were included for the present review.

Types of intervention {#sec2-2}
---------------------

Scaling and root planningOral hygiene instructions and maintenance therapyAdjunctive use of antibiotics.

Types of outcome measures {#sec2-3}
-------------------------

PTBLBWPTLBW.

Search strategy {#sec2-4}
---------------

We searched for the relevant studies using the databases PUBMED, MEDLINE, CINAHL, and EMBASE on the RCTs evaluating the influence of periodontal treatment on adverse pregnancy outcomes from January 2000 to October 2018. The keywords used for searching the studies were periodontitis, adverse pregnancy outcomes, periodontal therapy, and periodontal treatment, PTB, LBW and PTLBW. Relevant articles were also hand searched.

Study selection and data extraction {#sec2-5}
-----------------------------------

The eligibility for the inclusion of the studies for the present review was assessed by two reviewers independently. The reviewers appraised the full text of the studies which assessed the influence of periodontal therapy on any one of the three adverse pregnancy outcomes (PTB, LBW, and PTLBW). The data were extracted from the studies by each reviewer independently which included information about the study design, study population, timing of intervention, and type of intervention and the occurrence of adverse pregnancy outcomes in a separate sheet. Meta-analysis was not done because of heterogeneity attributed to the variations in the timing of periodontal treatment, type of periodontal intervention, and the type of periodontal disease among the studies included in this review.

Quality assessment {#sec2-6}
------------------

Cochrane collaboration tool for assessing the risk of bias was used to assess the quality of the studies included in this review.\[[@ref13]\] The tool helps to determine the internal validity of an intervention; usually, a treatment to control or eliminate a disease or a preventive measure to reduce the risk of having the disease. The source of bias in each study was independently appraised by two reviewers and judged as having an unclear, high, or low risk of bias. No study was excluded based on the Cochrane risk of bias tool.

Risk of bias in the studies included for review {#sec2-7}
-----------------------------------------------

Among the nineteen studies, thirteen studies \[[@ref3][@ref4][@ref5][@ref6][@ref7][@ref8][@ref14][@ref15][@ref16][@ref17][@ref18][@ref19][@ref20]\] have reported adequate randomization while allocation concealment was reported only in seven studies.\[[@ref4][@ref7][@ref17][@ref18][@ref20][@ref21][@ref22]\] Proper blinding of the participants and personnel was done in eight studies.\[[@ref3][@ref6][@ref7][@ref15][@ref16][@ref17][@ref22][@ref23]\] The outcome was assessed by the blinded investigator in eight studies.\[[@ref6][@ref7][@ref15][@ref16][@ref17][@ref21][@ref23][@ref24]\] Eleven studies \[[@ref4][@ref5][@ref6][@ref15][@ref17][@ref18][@ref19][@ref21][@ref24]\] were categorized having a low risk of bias based on incomplete data. Twelve studies \[[@ref3][@ref4][@ref5][@ref6][@ref12][@ref14][@ref15][@ref16][@ref18][@ref19][@ref22][@ref25]\] discussed the study outcomes in a prespecified way \[[Table 1](#T1){ref-type="table"}\]. Majority of the studies have not explicitly explained about the adjustment of confounders such as age, gender, socioeconomic status, history of PTB, bacterial vaginosis, gestational diabetes, prenatal care, and maternal weight gain except for six studies \[[@ref3][@ref15][@ref16][@ref19][@ref21][@ref23]\] which controlled for the majority of confounders. This is one of the methodological characteristics used for the assessment of individual trials based on Cochrane collaboration tool.

###### 

Quality of the studies assessed using the Cochrane risk of bias tool

  Author/years                                   Random sequence generation   Allocation concealment   Blinding of participants and personnel   Blinding of outcome assessment   Incomplete outcome data   Selective reporting
  ---------------------------------------------- ---------------------------- ------------------------ ---------------------------------------- -------------------------------- ------------------------- ---------------------
  López *et al*./2002\[[@ref15]\]                Low                          Unclear                  Low                                      Low                              Low                       Low
  Jeffcoat *et al*./2003\[[@ref7]\]              Low                          Low                      Low                                      Low                              High                      High
  López *et al*./2005\[[@ref21]\]                Unclear                      Low                      Low                                      Low                              Low                       Unclear
  Michalowicz *et al*./2006\[[@ref3]\]           Low                          Unclear                  Low                                      Low                              Unclear                   Low
  Offenbacher *et al*./2006\[[@ref22]\]          Low                          Unclear                  Low                                      High                             High                      Low
  Sadatmansouri *et al*./2006\[[@ref8]\]         Low                          High                     High                                     High                             Unclear                   Low
  Tarannum and Faizuddin/2007\[[@ref14]\]        Low                          Unclear                  High                                     High                             Low                       Low
  Gazolla *et al*./2007\[[@ref2]\]               Unclear                      High                     High                                     High                             High                      Low
  Newnham *et al*./2009\[[@ref19]\]              Low                          Unclear                  High                                     Low                              Low                       Low
  Radnai *et al*./2009\[[@ref6]\]                Low                          Unclear                  Low                                      Low                              Low                       Low
  Offenbacher *et al*./2009\[[@ref16]\]          Low                          Unclear                  High                                     Low                              Unclear                   Low
  Macones *et al*./2010\[[@ref17]\]              Low                          Low                      Low                                      Low                              Low                       High
  Sant'Ana *et al*./2011\[[@ref24]\]             Unclear                      High                     Unclear                                  Unclear                          Low                       High
  Oliveira *et al*./2011\[[@ref23]\]             High                         Unclear                  Low                                      Low                              Low                       High
  Pirie *et al*./2013\[[@ref4]\]                 Low                          Low                      Low                                      Low                              Low                       Low
  Weidlich *et al*./2013\[[@ref18]\]             Low                          Low                      High                                     Low                              Low                       Low
  Reddy *et al*./2014\[[@ref5]\]                 Low                          Unclear                  High                                     High                             Unclear                   Low
  Khairnar *et al*./2015\[[@ref20]\]             Low                          Low                      High                                     Unclear                          High                      High
  Penova-Veselinovic *et al*./2015\[[@ref25]\]   Unclear                      High                     High                                     Unclear                          High                      Low

RESULTS {#sec1-3}
=======

Total studies identified through the database search were 967. After assessing the studies for the eligibility criteria, 24 studies considering the title and abstract were selected for full-text reading \[[Figure 1](#F1){ref-type="fig"}\]. Five studies have been excluded as they did not report the incidence of birth outcomes,\[[@ref26]\] did not evaluate clinical parameters,\[[@ref27]\] participants were from a part of a cohort study,\[[@ref28][@ref29]\] and results of the study were analyzed as per the success of periodontal treatment.\[[@ref30]\]

![Flow chart depicting the process of literature search](JISP-24-7-g001){#F1}

Patient characteristics {#sec2-8}
-----------------------

About 8761 pregnant women were included in 19 trials. The majority of participants in the trials included were in the second trimester of pregnancy. The mean age of the participants was 25.6 ± 2.5 years \[[Table 2](#T2){ref-type="table"}\].

###### 

Baseline Characteristics of the studies included in the review

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author/Year                              Country            Total number of subjects   Timing of intervention   Pregnancy outcome   Odds ratio/Relative risk/Incidence/Risk ratio
  ---------------------------------------- ------------------ -------------------------- ------------------------ ------------------- -----------------------------------------------
  1.Lopez/2002\[[@ref15]\]                 Chile              Treatment group - 200\     9-21 weeks               PTLBW\              OR -6.67 (1.89-23.52)\
                                                              Control group -200                                  LBW\                OR -6.96 (0.81-59.62)\
                                                                                                                  PTB                 OR-6.11 (1.3-28.53)

  2.Jeffcoat/2003\[[@ref7]\]               USA                Treatment group- 246\      21-25 weeks              PTB                 OR-0.45 (0.15-1.28)/\
                                                              Control group- 120                                                      RR-1.4 (0.7-2.9)

  3.Lopez/2005\[[@ref21]\]                 Chile              Treatment group-580\       28 weeks                 PTB\                OR-4.11 (1.73-9.73)\
                                                              Control group-290                                   LBW\                OR-1.47 (0.32-6.54)\
                                                                                                                  PTLBW               OR-3.26 (1.56-6.83)

  4.Michalowicz/2006\[[@ref3]\]            USA                Treatment group -413\      13-17 weeks              PTB\                Risk ratio1.17 (0.74,1.85)\
                                                              Control group-412                                   LBW                 Risk ratio0.92 (0.58,1.45)

  5.Offenbacher 2006\[[@ref22]\]           USA                treatment group-56\        21 weeks                 PTB                 OR-0.26 (0.08-0.85)
                                                              Control group-53.                                                       

  6.Sadatmonsouri/2006\[[@ref8]\]          Iran               Treatment group - 15\      13-20 week               PTBLBW              RR-0.12 (0.01,2.45)\
                                                              Control group-15                                                        RR-0.31 (0.01,8.28)

  7.Gazolla/2007\[[@ref2]\]                Brazil             Treatment group-266\       \<22 weeks               PTLBW               7.5% Incidence
                                                              Control group-62                                                        

  8\. Tarrannum/2007\[[@ref14]\]           India              Treatment group-100\       \<22 weeks               PTB\                76.4% Incidence\
                                                              Control group-100                                   LBW                 53.9% Incidence

  9.Radnai/2009\[[@ref6]\]                 Hungary            Treatment group-41\        24 weeks                 PTLBW\              OR- 4.6 (1.3-15.5)\
                                                              Control group-40                                    PTB\                OR- 3.4 (1.3-8.6)\
                                                                                                                  LBW                 OR - 4.3 (1.5-12.6)

  10.Newnham/2009\[[@ref19]\]              Australia          Treatment group-538\       20 weeks                 PTB                 OR -1.05 (0.7-1.58)
                                                              Control group-540                                                       

  11\. Offenbacher/2009\[[@ref16]\]        USA                Treatment group-903\       23 weeks                 PTB\                OR-1.22 (0.09-1.66)\
                                                              Control group-903                                   LBW                 OR-1.01 (0.72-1.42)

  12\. Macones/2010\[[@ref17]\]            Philadelphia       Treatment group-376\       NA                       PTB\                RR - 1.38 (0.92--2.08)\
                                                              Control group-380                                   PTLBW               RR -1.19 (0.62-2.28)

  13.Santana/2011\[[@ref24]\]              Brazil             Treatment group-16\        9-24 weeks               PTB                 OR-13.50 (1.47-123.45)
                                                              Control group-15                                                        

  14\. Oliveria/2011\[[@ref23]\]           Brazil             Treatment group-122\       12-20 weeks              PTB\                RR-0.927 (0.601-1.431)\
                                                              Control group-124                                   LBW\                RR-0.735 (0.459-1.179)\
                                                                                                                  PTLBW               RR-0.915 (0.561-1.493)

  15\. Weidlich/2011\[[@ref18]\]           Brazil             Treatment group-122\       12-20 weeks              PTB                 RR-1.25 (0.87,1.78)
                                                              Control group-124                                                       

  16\. Pirie/2013\[[@ref4]\]               Northern ireland   Treatment group-49\        22 weeks                 PTB-\               RR-4.08 (0.47-35.24)\
                                                              Control group-50                                    LBW-                RR-3.06 (0.33-28.43)

  17\. Reddy/2014\[[@ref5]\]               India              Treatment group-49\        22 weeks                 PTB\                10% Incidence\
                                                              Control group-50                                    LBW                 20%Incidence

  18.Khairnar/2015\[[@ref20]\]             India              Treatment group-50\        \<22 weeks               PTB\                OR -0.54 (0.38-0.77)\
                                                              Control group-50                                    LBW                 OR -0.78 (0.50-1.21)

  19.Penova vaselinovic/2015\[[@ref25]\]   Australia          Treatment group-50\        \<22 weeks               PTB                 OR -0.33 (0.04-2.99)
                                                              Control group-50                                                        
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

OR-Odds ratio, RR-Relative risk, NA -- Not applicable, PTLBW-Preterm low birth weight, PTB- Preterm birth, LBW-Low birth weight

Population characteristics {#sec2-9}
--------------------------

The studies were conducted on different countries among homogenous population in Chile,\[[@ref15][@ref21]\] Iran,\[[@ref8]\] India,\[[@ref5][@ref14]\] Hungary,\[[@ref6]\] Ireland,\[[@ref4][@ref11]\] Brazil \[[@ref22]\] and heterogeneous population in U.S.A \[[@ref3][@ref7][@ref16][@ref17][@ref18][@ref22][@ref23]\] and Australia.\[[@ref19]\] The studies conducted among homogeneous population showed positive influence of periodontal therapy on the reduction of adverse pregnancy outcomes compared to studies done in heterogeneous population.

Study location {#sec2-10}
--------------

When compared to single center trials with a defined population,\[[@ref6][@ref7][@ref14][@ref15][@ref21][@ref22]\] multicenter trials with a larger population \[[@ref3][@ref16][@ref17]\] showed negative results due to differences among the study population.

Criteria used for defining periodontal disease {#sec2-11}
----------------------------------------------

The parameters used for assessing the periodontal status in the studies were probing depth, clinical attachment level (CAL), and bleeding on probing. Among the studies included in this review, there is a disparity in the criteria used for defining the periodontal disease. Some studies used CAL as the only criteria \[[@ref7][@ref14][@ref17][@ref22]\] to define periodontal disease, whereas other studies \[[@ref3][@ref5][@ref6][@ref12][@ref21]\] used combination of probing depth, CAL, and bleeding on probing.

Periodontal intervention {#sec2-12}
------------------------

There was heterogeneity among the studies considering the treatment options provided to pregnant mothers. The participants in the treatment group received oral hygiene instructions, full-mouth scaling, and root planning either in a single visit or multivisits and was followed till delivery. Only two studies \[[@ref7][@ref15]\] advocated the use of antibiotics as a part of the intervention. However, the results did not show any significant difference over the additional usage of antibiotics. Nine \[[@ref7][@ref8][@ref14][@ref15][@ref17][@ref18][@ref19][@ref20]\] of the RCTs used root planning as the only treatment option. The control group in the studies did not receive any active periodontal therapy during pregnancy \[[Table 3](#T3){ref-type="table"}\].

###### 

Periodontal characteristics of the participants from the studies included for the review

  Author/years                                   Definition of periodontal disease                                                                                                                       Type of periodontal disease   Type of intervention                                                                    Conclusion from studies
  ---------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------- --------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------
  López *et al*./2002\[[@ref15]\]                4 teeth with 1 site with PD ≥4 mm and CAL ≥3 mm                                                                                                         Mild to moderate              SRP and rinsing with 0.12% CHX maintenance 2-3 weeks till delivery                      Periodontal therapy significantly reduces rates of PLBW
  Jeffcoat *et al*./2003\[[@ref7]\]              \>3 sites with CAL loss ≥3mm                                                                                                                            Moderate                      SRP and rinsing with CHX maintenance 2-3 weeks till delivery                            SRP reduces PTB
  López *et al*./2005\[[@ref21]\]                ≥25% of sites with BOP and no sites with CAL \>2 mm                                                                                                     gingivitis                    SRP with 0.12% CHX                                                                      Periodontal treatment significantly reduces rate of PTB/LBW
  Michalowicz *et al*./2006\[[@ref3]\]           PD ≥4 mm and CAL ≥2 mm and BOP at≥35% of tooth sites                                                                                                    Moderate                      SRP and OHI till needed till delivery                                                   Periodontal treatment improves periodontal disease but does not alter pregnancy outcomes
  Offenbacher *et al*./2006\[[@ref22]\]          ≥2 sites with ≥5 mm PD with CAL 1-2 mm ≥1 site and PD ≥5 mm                                                                                             Mild                          SRP with the use of sonic brush                                                         Potential benefits of periodontal treatment on pregnancy outcomes
  Sadatmonsouri *et al*./2006\[[@ref8]\]         ≥ 4 mm PD at≥4 teeth≥3 mm CAL at same site                                                                                                              Moderate to severe            SRP with 0.12% CHX                                                                      Periodontal therapy reduces the PTB rate
  Gazolla *et al*./2007\[[@ref2]\]               P1 - ≥4 teeth PD 4-5 mm and CAL - 3-5 mm. P2 - ≥4 teeth with PD and CAL of 5-7 mm at the same site. P3 - ≥4 teeth withPD and CAL 7mm at the same site   Moderate to severe            SRP, OHI with 0.12% CHX                                                                 Periodontal disease is significantly related to PTLBW
  Tarannum and Faizuddin/2007\[[@ref14]\]        ≥2 mm attachment loss at ≥50% of examined sites                                                                                                         Moderate to severe            SRP with CHX and maintenance every 3-4 weeks                                            Periodontal therapy reduces the risk of PTB
  Radnai *et al*./2009\[[@ref6]\]                ≥4 mm PD atleast at one site, BOP for ≥50% of teeth                                                                                                     Mild to moderate              SRP and plaque control                                                                  Periodontal treatment completed before 35th week have beneficial effect on birth weight and time of delivery
  Newnham *et al*./2009\[[@ref19]\]              PD ≥4 mm at ≥12 probing sites                                                                                                                           Mild to moderate              SRP with CHX and maintenance every 3 weeks till delivery                                Periodontal treatment does not improve pregnancy outcomes
  Offenbacher *et al*./2009\[[@ref16]\]          ≥20 teeth with ≥3 sites with CAL ≥3 mm                                                                                                                  Mild                          SRP                                                                                     Periodontal therapy did not reduce incidence of preterm delivery
  Macones *et al*./2010\[[@ref17]\]              CAL ≥3 mm on ≥3 teeth and ≥5 mm on ≥3 teeth                                                                                                             Moderate to severe            SRP                                                                                     Periodontal treatment does not reduce the incidence of pregnancy outcomes
  Sant'Ana *et al*./2011\[[@ref24]\]             NA                                                                                                                                                      NA                            SRP and OHI                                                                             Periodontal treatment during second trimester did not reduce the risk for PTB, LBW and PTLBW
  Oliveira *et al*./2011\[[@ref23]\]             4 or more teeth with one or more sites with PD ≥4 mm and CAL ≥3 mm                                                                                      Mild to moderate              SRP with maintenance every 3 weeks till delivery                                        Periodontal treatment during second trimester reduces the risk for PTB, LBW and PTLBW
  Weidlich *et al*./2011\[[@ref18]\]             4 or more teeth with one or more sites with PD ≥4 mm and CAL ≥3 mm                                                                                      Mild to moderate              SRP with maintenance every 3 weeks till delivery                                        Periodontal treatment during second trimester reduces the risk for PTB, LBW and PTLBW
  Pirie/2013\[[@ref4]\]                          ≥4 mm at 4 or more sites and CAL ≥at 4 or more sites                                                                                                    Mild to moderate              SRP                                                                                     Nonsurgical periodontal therapy completed at 20-24 weeks did not reduce the risk of adverse pregnancy outcomes
  Reddy *et al*./2014\[[@ref5]\]                 Loss of attachment ≥1 mm, PPD ≥4 mm at 3 to 4 sites in \>4 teeth                                                                                        Mild to moderate              SRP                                                                                     Treatment reduces pregnancy outcomes
  Khairnar *et al*./2015\[[@ref20]\]             PD \>2 mm, CAL at 50% examined sites                                                                                                                    Mild to moderate              SRP with 0.2% CHX rinse once a day                                                      Nonsurgical periodontal therapy can significantly reduce the risk of PTB and LBW deliveries
  Penova-Veselinovic *et al*./2015\[[@ref25]\]   PD ≥3.5mmat 25% of sites                                                                                                                                Mild to moderate              Nonsurgical debridement of sub and supragingival calculus and overhanging restoration   Periodontal disease treatment in pregnancy improves periodontal parameters with no effect on pregnancy outcome

NA -- Not applicable; SRP -- Scaling and root planning; PD -- Probing depth; CAL -- Clinical attachment level; BOP -- Bleeding on probing; RR -- Relative risk; PTB -- Preterm birth; LBW -- Low birth weight; PTLBW -- Preterm LBW; CHX -- Chlorhexidine; OHI -- Oral hygiene instruction

Optimal timing of treatment {#sec2-13}
---------------------------

The timing of periodontal intervention is a crucial factor which determines the success of periodontal treatment in reducing the adverse pregnancy outcomes. Most of the studies have discussed the optimal timing of periodontal intervention, which was between 28 and 32 weeks of gestation.\[[@ref2][@ref14][@ref20][@ref21][@ref25]\]

Outcome measures considered {#sec2-14}
---------------------------

The outcome measures considered were the occurrence of PTB, LBW, and PTLBW. Twelve \[[@ref2][@ref5][@ref6][@ref7][@ref8][@ref14][@ref15][@ref20][@ref21][@ref22][@ref24][@ref25]\] of 19 studies showed the positive influence of periodontal therapy on pregnancy outcomes, and seven studies \[[@ref3][@ref4][@ref16][@ref17][@ref18][@ref19][@ref23]\] reported no significant effect of periodontal therapy on pregnancy outcomes. Among the studies included in the present review, the occurrence of PTB \[[@ref3][@ref4][@ref12][@ref13][@ref17][@ref18][@ref20][@ref21][@ref22][@ref25][@ref26]\] among the individuals who received periodontal therapy ranged from 0% to 53.5%, while in the control group, the range was 6.38%--72%. The occurrence of LBW \[[@ref5][@ref14][@ref15][@ref16][@ref17][@ref18][@ref19][@ref21][@ref23]\] among the individuals treated for periodontal disease ranged from 0% to 36%, and in the control group, it varied from 1.15% to 53.9%. The incidence of PTLBW \[[@ref2][@ref6][@ref7][@ref15][@ref18][@ref21][@ref23]\] among the test group ranged from 0% to 26.7%, whereas in the control group, it ranged from 4.15% to 79%. The odds of decreased occurrence of PTB, LBW, and PTLBW among the participants who received periodontal therapy when compared to the control group ranged 0.26--13.50, 1.008--4.3, and 1.05--5.49, consecutively.

DISCUSSION {#sec1-4}
==========

Adverse pregnancy outcomes remain an important public health problem. Among the adverse pregnancy outcomes, PTB has been estimated as the cause for 28% of neonatal deaths.\[[@ref31]\] The other adverse pregnancy outcomes are LBW, preeclampsia, and gestational diabetes. The proven risk factors for the adverse pregnancy outcomes were young and advanced maternal age, multiple gestations, previous PTB, short cervix, low educational status, and fetal genotype.\[[@ref1]\] Periodontal disease among pregnant women poses a considerable risk for adverse pregnancy outcomes. Researchers have suggested that translocation of periodontal pathogens to the fetal placental unit or the release of inflammatory mediators by the periodontal pathogens, which spreads through hematogenous route, affects the fetus. Numerous epidemiological studies evaluating the relationship between maternal periodontal disease and adverse pregnancy outcomes have reported conflicting results.

Consistent evidence from systematic reviews and meta-analysis indicates that pregnant women with periodontal disease are at increased risk of adverse pregnancy outcomes.\[[@ref32][@ref33][@ref34]\] A meta-analysis concluded that pregnant women with periodontal disease have a 2.8-fold increased risk of PTB.\[[@ref32]\] Hence, periodontal care should be given to pregnant mothers to prevent the occurrence of adverse pregnancy outcomes. The mechanism of how periodontal treatment could reduce the occurrence of adverse pregnancy outcomes is uncertain. The possible explanation might be the treatment for periodontal disease reduces the oral bacterial load thereby minimizing the risk of bacteremia and seeding of the fetal placental unit with pathogens which cause infection and adverse pregnancy outcomes. Another possible mechanism might be the reduction in oral bacterial load would reduce the production of inflammatory mediators such as cytokines and prostaglandins associated with adverse pregnancy outcomes.\[[@ref22][@ref35]\]

The effectiveness of periodontal therapy in reducing the occurrence of adverse pregnancy outcomes may vary according to the study location and population characteristics. Studies done in USA \[[@ref3][@ref7][@ref16][@ref17]\] Australia \[[@ref19]\] did not report the significant difference in the occurrence of PTB, LBW, and PTLBW, whereas studies done in Chile, Brazil, India, and Hungary \[[@ref6][@ref14][@ref15][@ref16][@ref21]\] showed significant difference among them. The disparity maybe attributed to the sharing of similar characteristics with reference to age, gender, and exposure of risk factors of PTB among homogeneous population.

Among the studies included in this review, single center trials with a defined population \[[@ref6][@ref7][@ref14][@ref15][@ref21][@ref22]\] provided positive influence of periodontal treatment when compared to multicenter trials with a larger population \[[@ref3][@ref16][@ref17]\] which showed negative results. The inconsistency of the study results can be attributed to the differences in the study population and providing patient care in case of multicenter trials.

Timing of periodontal intervention is a crucial factor which determines the efficacy of reducing signs and symptoms of periodontal disease and associated inflammatory response thereby its impact on reducing adverse pregnancy outcomes. Most of the studies discussed the optimal timing of treatment to be between 28 and 32 weeks.\[[@ref2][@ref14][@ref20][@ref21][@ref25]\] While in some studies, periodontal intervention was carried out before 24 or 28^th^ week,\[[@ref3][@ref7][@ref8][@ref23]\] and in a study done by Jeffcoat *et al*.,\[[@ref7]\] the treatment was given before 35^th^ week of gestation. Majority of large clinical trials did not show positive influence of periodontal therapy on adverse pregnancy outcomes when treatment was given in the second trimester.\[[@ref3][@ref16][@ref17]\] The underlying mechanism being the intervention provided too late because by the time periodontal bacteria would have reached the fetoplacental unit and have initiated the process of adverse pregnancy outcomes.\[[@ref36]\] Hence, if the adverse pregnancy outcomes could be linked to the presence of periodontal pathogens and inflammatory mediators, the correct timing of treatment could be before pregnancy or in the early stages of pregnancy.

The criteria used for defining the periodontal disease also differed among the studies considered for the review. Four studies \[[@ref7][@ref14][@ref17][@ref22]\] used CAL as the only criteria to define periodontal disease, whereas other studies \[[@ref3][@ref5][@ref6][@ref21]\] used a combination of probing depth, CAL, and bleeding on probing. Hence, standardized criteria should be used for defining periodontal disease to assess the influence of periodontal therapy on the occurrence of adverse pregnancy outcomes without any disparity among the study results.

Most of the studies included in this review assessed the influence of periodontal treatment on PTB and LBW and only a few studies reported stillbirth as one of the primary outcomes.\[[@ref3][@ref19]\] Most of the studies reporting the success of periodontal therapy in this review considered mild to moderate cases of periodontitis because in severe cases, there is systemic dissemination of microorganisms and the infection does not completely resolve.\[[@ref11][@ref37][@ref38]\] Hence, the study results cannot be generalized to individuals with severe periodontal disease.

Among the studies included in the review, the treatment and control groups were comparable with reference to the periodontal characteristics and exposure of risk factors. In majority of the studies, the treatment group received full-mouth scaling, root planing with oral hygiene instructions and followed by maintenance till delivery.\[[@ref3][@ref14]\] Few studies reported the use of chlorhexidine rinse as an adjunct to scaling and root planing \[[@ref2][@ref7][@ref8][@ref21]\] with significant results for control of periodontal disease. Among the control groups, only periodontal examination was done before delivery in some studies.\[[@ref3][@ref6][@ref21]\] While in few studies, control groups received periodontal treatment after delivery.\[[@ref2][@ref14]\] Both the groups were followed until delivery for the assessment of birth outcomes.

Studies with high risk or unclear risk of bias \[[@ref2][@ref5][@ref6][@ref7][@ref8][@ref14][@ref15][@ref20][@ref21][@ref22][@ref24][@ref25]\] supported the beneficial influence of periodontal treatment in contrary to studies with low-risk of bias.\[[@ref3][@ref4][@ref16][@ref17][@ref18][@ref19][@ref23]\] Hence, the influence of periodontal treatment on adverse pregnancy outcomes is uncertain, and further studies without the risk of bias evaluating the influence of periodontal treatment on adverse pregnancy outcomes should be conducted.

Previous systematic reviews and meta-analysis revealed a reduction in the occurrence of PTB with periodontal treatment in the population with the high-risk of the occurrence of adverse pregnancy outcomes.\[[@ref11][@ref39]\] However, in case of moderate risk of occurrence of events, the results were not statistically significant.\[[@ref11][@ref37][@ref38]\] Polyzos *et al*. in his meta-analysis found that periodontal disease during pregnancy had no significant effect on the reduction of PTB rate (odds ration \[OR\] -- 1.15, 95% confidence interval \[CI\]: 0.95--1.40)\[[@ref40]\] supported by meta-analysis performed by Chambrone *et al*. and Fogacci *et al*.\[[@ref12][@ref41]\]

In contrast to the above findings, George *et al*. in his meta-analysis found that periodontal treatment during pregnancy significantly reduces PTB (OR = 0.65, CI: 0.45--0.93).\[[@ref39]\] In the recent systematic review, da Silva *et al*, concluded that intra-pregnancy non-surgical periodontal therapy decrease the level of inflammatory biomarkers from GCF and serum blood but it did not reduce the occurrence of adverse pregnancy outcomes.\[[@ref42]\] The differences reported in the study findings can be explained by the variation in strategies applied and the trials included for meta-analysis.

The strength of this systematic review is pertained to the inclusion of RCTs of varied methodological quality. The probable limitations of this systematic review could be the search for the relevant studies pertaining to three databases only, and the studies in the English language only were included. With best available evidence, it is sufficient to state that scaling and root planing alone is not effective in reducing the occurrence of adverse pregnancy outcomes. Hence, this review highlights the need of further multicentered RCTs to be conducted with strict protocol, clearly defined criteria for the periodontal disease, and intervention during the early stages of pregnancy or preconception to assess the influence of periodontal therapy on adverse pregnancy outcomes.

CONCLUSION {#sec1-5}
==========

The present systematic review concluded that nonsurgical periodontal therapy during pregnancy is safe, but it does not completely reduce the occurrence of adverse pregnancy outcomes. Since nonsurgical periodontal therapy shows significant reduction in the occurrence of adverse pregnancy outcomes among high-risk patients, it can be included as a part of antenatal care.
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